Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.011 | 0.8 |